Core Insights - Dolby Laboratories reported Q3 FY2025 earnings with GAAP revenue of $315.5 million, exceeding analyst expectations of $305.2 million and up from $288.8 million in Q3 FY2024, indicating a year-over-year growth of 9.3% [1][2] - Non-GAAP earnings per share reached $0.78, surpassing estimates of $0.71, reflecting a 9.9% increase from the previous year [1][2] - The company experienced higher GAAP operating income of $47.6 million, a 29.3% increase year-over-year, and net income of $46.1 million, up 20.1% from Q3 FY2024 [1][2] Financial Performance - Licensing revenue grew 8.5% year-over-year to $289.9 million, with broadcast licensing accounting for 38% and mobile licensing for 19% of total licensing revenue [5][6] - Gross margin was reported at 86.0%, slightly down from 87.6% in Q3 FY2024, while operating expenses rose 3.5% to $223.9 million [2][8] - The company maintained a strong net income growth of 19.8% year-over-year, alongside a share buyback of approximately $40 million and a quarterly dividend of $0.33 per share [8][12] Strategic Focus - Dolby Laboratories is recognized for its innovations in audio and visual technologies, such as Dolby Atmos and Dolby Vision, which are widely integrated across various devices and platforms [3][9] - The company relies heavily on licensing, which constituted 93% of total revenue in FY2024, and focuses on expanding its patent portfolio and relationships with manufacturers and content providers [4][10] - Recent partnerships in the automotive sector with companies like Audi and Tata, as well as new product launches in consumer electronics, highlight Dolby's expanding market presence [7][10] Future Outlook - Management projects Q4 FY2025 GAAP revenue between $288 million and $318 million, with full-year FY2025 revenue forecasted at $1.33 billion to $1.36 billion [11] - Operating expenses for FY2025 are expected to reach up to $920 million, with non-GAAP earnings per share projected in the range of $3.88 to $4.03 [11] - The company maintains a cautious outlook due to macroeconomic uncertainties, including trade restrictions and supply chain disruptions, which may impact near-term visibility [12]

Core Insights - Dolby Laboratories, Inc. (DLB) reported strong third-quarter fiscal 2025 results with non-GAAP earnings per share (EPS) of 78 cents, exceeding the Zacks Consensus Estimate by 8.3% and up from 71 cents in the prior-year quarter [1][8] - Total revenues reached $315.6 million, an increase from $288.8 million year-over-year, also surpassing the Zacks Consensus Estimate by 3.9% [1][8] - The growth was primarily driven by higher revenues in the Licensing segment and the Products and Services segment [1][8] Financial Performance - Licensing revenues were $289.9 million, reflecting an 8.5% year-over-year increase, reaching the upper end of the company's guidance due to earlier-than-expected activity [4][8] - Products and Services revenues increased by 18% year-over-year to $25.6 million [4] - Gross profit for the quarter was $271.5 million, compared to $253.2 million in the year-ago quarter, while total operating expenses rose to $223.9 million from $216.4 million [6] Cash Flow and Liquidity - For the fiscal year to date ending June 27, 2025, Dolby generated $349.4 million in net cash from operating activities [9] - As of June 27, 2025, the company had $698.6 million in cash and cash equivalents against total liabilities of $581.8 million [9] - During the quarter, Dolby repurchased approximately 526,000 shares for around $40 million and declared a cash dividend of 33 cents per share [10] Future Outlook - For the fourth quarter of fiscal 2025, Dolby estimates revenues between $288 million and $318 million, with GAAP EPS of 28-43 cents and non-GAAP EPS between 61 cents and 76 cents [11] - The company expects full fiscal 2025 revenues in the range of $1.33 billion to $1.36 billion, with licensing revenues projected between $1.23 billion and $1.26 billion [12][13] Market Engagement - Dolby continues to see robust engagement from creators, distributors, and device manufacturers, with Dolby Atmos and Dolby Vision expanding across various content types and devices [2] - Major sporting events have been broadcast in Dolby, and partnerships with companies like Audi and Motorola have enhanced Dolby's presence in the automotive and mobile sectors [14][15]

Core Insights - Dolby Laboratories reported revenue of $315.55 million for the quarter ended June 2025, marking a year-over-year increase of 9.3% and exceeding the Zacks Consensus Estimate of $303.67 million by 3.91% [1] - The company achieved an EPS of $0.78, up from $0.71 a year ago, resulting in an EPS surprise of 8.33% compared to the consensus estimate of $0.72 [1] Revenue Breakdown - Licensing revenue was $289.91 million, surpassing the estimated $281.01 million, reflecting an 8.6% year-over-year increase [4] - Products and services revenue reached $25.64 million, exceeding the average estimate of $22.66 million, with an 18% year-over-year change [4] - PC market licensing revenue was $33.59 million, compared to the estimated $28.41 million, showing a 21.7% increase year-over-year [4] - Other market licensing revenue was $60.66 million, slightly below the $65.55 million estimate, but still representing a 15.3% year-over-year increase [4] - Consumer Electronics (CE) market licensing revenue was $28.07 million, below the estimated $30.03 million, indicating a year-over-year decline of 1% [4] - Broadcast market licensing revenue was $111.29 million, exceeding the estimated $100.27 million, with a year-over-year increase of 16.6% [4] - Mobile market licensing revenue was $56.3 million, below the estimated $60.99 million, reflecting a year-over-year decline of 10.8% [4] Gross Margin Analysis - Gross margin for licensing was reported at $268.19 million, above the average estimate of $263.61 million [4] - Gross margin for products and services was $3.35 million, significantly higher than the average estimate of $1.11 million [4] Stock Performance - Over the past month, shares of Dolby Laboratories have returned -0.4%, while the Zacks S&P 500 composite has increased by 2.7% [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Financial Data and Key Metrics Changes - Q3 revenue was $316 million, up 9% year over year, with licensing revenue at $290 million, also up 9% year over year [15] - Product and services revenue was $26 million, up 18% year over year [15] - Non-GAAP earnings per diluted share were $0.78, above the high end of guidance due to higher revenue and lower operating expenses [17] - Cash and investments at the end of the quarter totaled $777 million, with $68 million generated in operating cash flow [17] Business Line Data and Key Metrics Changes - Broadcast licensing revenue grew 17% year over year, while mobile licensing revenue declined 11% year over year, and PC licensing revenue grew 22% year over year [16] - Full year expectations indicate flat growth for broadcast, mid-teens growth for other end markets, and low teens decline for consumer electronics [16] Market Data and Key Metrics Changes - Strong momentum in the automotive sector with partnerships with major OEMs like Audi, Tata, and Mahindra [10][11] - Increased adoption of Dolby Vision in mobile devices, with Motorola and Xiaomi launching new products featuring Dolby technologies [10][11] Company Strategy and Development Direction - The company continues to focus on expanding Dolby Atmos and Dolby Vision across various content types and device categories [12] - There is a strong emphasis on engaging with content creators and distributors to enhance the ecosystem [12] Management Comments on Operating Environment and Future Outlook - The macro environment remains uncertain, but the company maintains its guidance for the full year, expecting revenues between $1.33 billion and $1.36 billion [14] - Management is optimistic about long-term growth prospects, citing strong engagement and a solid financial position [15] Other Important Information - The company repurchased $40 million worth of common stock and declared a $0.33 dividend, up 10% from the previous year [17] - The company expects Q4 revenue to be between $288 million and $318 million, with licensing revenue ranging from $263 million to $293 million [19] Q&A Session Summary Question: Impact of ATSC 3.0 transition on Dolby Atmos and Vision adoption - Management does not anticipate any impact from the transition, as Dolby's codecs are supported within the standards [22] Question: Shipment volume expectations in Q4 guidance - Management noted slight headwinds for the year, with softness in shipments particularly in set-top boxes and consumer electronics [24] Question: Trade agreement certainty and its impact on Dolby adoption - Management acknowledged some improvement in trade agreements but noted that uncertainty still exists, though engagement for Dolby technologies remains strong [28] Question: Opportunity for Dolby Vision in automotive outside of China - Management sees significant opportunities for expanding in-car entertainment experiences beyond China [32] Question: Achieving double-digit growth in the current environment - Management believes it is achievable, citing strong growth in Dolby Atmos and Vision categories [36]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 27, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0199783 (State or other ...

Exhibit 99.1 Dolby Laboratories Reports Third Quarter 2025 Financial Results SAN FRANCISCO, July 31, 2025 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2025. "We had solid results in Q3 and we continue to see strong engagement with creators, distributors and device manufacturers," said Kevin Yeaman, President and CEO, Dolby Laboratories. "The number of experiences in Dolby Atmos and Dolby Vision continues to grow across music, sports, p ...

Group 1 - The article discusses the potential for investment opportunities in DLB, indicating a possible beneficial long position may be initiated within the next 72 hours [1] - The author emphasizes the importance of conducting due diligence and research prior to any investment decisions, particularly in high-risk trading styles [2] - It is noted that past performance does not guarantee future results, and no specific investment recommendations are provided [3]

Core Viewpoint - Dolby Laboratories, Inc. will announce its financial results for Q3 fiscal year 2025 on July 31, 2025, after market close [1] Financial Results Announcement - The financial results will be discussed in a conference call led by Dolby management at 2:00 p.m. PT (5:00 p.m. ET) on the same day [1] - Access to the teleconference can be obtained via a dedicated website or by dialing a specific phone number with a confirmation code [2] Replay and Archive Information - A replay of the conference call will be available from 5:00 p.m. PT on July 31, 2025, until 8:59 p.m. PT on August 7, 2025 [3] - An archived version of the teleconference will also be accessible on the Dolby Laboratories investor relations website [3] Company Overview - Dolby Laboratories is recognized as a leader in immersive entertainment, providing experiences across various media including movies, TV, music, sports, and gaming [4] - The company collaborates with artists and brands to enhance entertainment through innovations like Dolby Atmos and Dolby Vision [4]

Core Viewpoint - Cognition Therapeutics, Inc. is advancing its investigational drug zervimesine (CT1812) for the treatment of mild-to-moderate Alzheimer's disease and dementia with Lewy bodies (DLB), with an end-of-Phase 2 meeting scheduled with the FDA to discuss Phase 2 study results and plans for a Phase 3 program [1][2][8] Group 1: Clinical Development - The company will hold an end-of-Phase 2 meeting with the FDA on July 9, 2025, to review the Phase 2 'SHINE' study results of zervimesine in Alzheimer's disease [1] - Cognition is also moving forward with plans for a registrational program for DLB based on positive results from the Phase 2 'SHIMMER' study [2] - An expanded access program for zervimesine in DLB is underway, with high interest from former SHIMMER participants [3] Group 2: Drug Information - Zervimesine (CT1812) is an oral, once-daily investigational drug targeting neurodegenerative diseases, specifically Alzheimer's and DLB, by potentially interrupting the toxic effects of harmful proteins in the brain [4] - The drug has been generally well tolerated in clinical studies to date [4] - The USAN Council has adopted zervimesine as the official name for CT1812 [5] Group 3: Company Overview - Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule therapeutics for age-related degenerative disorders of the central nervous system [6] - The company has completed Phase 2 studies for zervimesine in multiple conditions, including DLB and Alzheimer's disease, and is currently conducting an ongoing Phase 2 study in early Alzheimer's disease [6]

Summary of Dolby Laboratories (DLB) FY Conference June 04, 2025 Company Overview - **Company**: Dolby Laboratories (DLB) - **Industry**: Audio and Visual Technology - **Conference Date**: June 04, 2025 Key Points and Arguments 1. **Historical Growth**: Dolby has experienced growth through various product cycles, transitioning from analog to digital, and now to streaming technologies, indicating a resilient business model that adapts to technological changes [2][3][9] 2. **Recent Performance**: The business has been relatively flat over the last four years, but there are signs of growth returning, with an expected margin expansion of about 200 basis points as the business begins to grow again [3][51] 3. **Product Segmentation**: Dolby has broken out its revenue into foundational audio technologies and growth products like Dolby Atmos and Dolby Vision, which have shown significant growth [14][17] 4. **Revenue Composition**: Foundational audio technologies accounted for about 60% of licensing revenue last year, with expected low single-digit growth. In contrast, Dolby Atmos and Dolby Vision have grown at a compound annual growth rate (CAGR) of about 20% over the last four years, now making up 40% of licensing revenue [17][51] 5. **Ecosystem Focus**: Dolby emphasizes its role in the ecosystem of content creation and distribution, working closely with content creators, distributors, and device manufacturers to enhance the consumer experience [11][12] 6. **Technological Advancements**: Dolby Atmos allows for a more immersive audio experience by enabling sound mixing in a three-dimensional space, while Dolby Vision enhances visual quality with high dynamic range and color accuracy [20][24] 7. **New Business Model**: The introduction of OptiView, a SaaS model focused on real-time interactive digital experiences, particularly in mainstream sports and iGaming, is expected to enhance engagement and provide a competitive edge [30][31] 8. **Market Outlook**: The company anticipates stabilization in consumer device shipments, which will positively impact growth rates for Dolby Atmos and Dolby Vision, projecting a growth rate of 15-25% for these technologies [51] 9. **Impact of Macroeconomic Factors**: Tariffs and trade policies could pose slight headwinds, but the company has mechanisms in place to mitigate these risks, particularly in the mobile and automotive sectors [53][56] Additional Important Content 1. **Consumer Experience**: The focus on creating memorable experiences for consumers is central to Dolby's mission, with many users recalling their first experiences with Dolby technology [8][26] 2. **Cinema Expansion**: Dolby Cinema is expanding its presence, with plans to increase the number of screens significantly in the U.S. and enter new markets like India, capitalizing on the growing demand for premium movie experiences [66][68] 3. **Long-term Relationships**: Dolby aims to establish durable relationships with device manufacturers, ensuring fair pricing while maintaining high adoption rates for its technologies [61][62] This summary encapsulates the key insights from the conference, highlighting Dolby's strategic focus on growth, technological innovation, and market adaptation.